| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-073 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于股东完成证券非交易过户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 | 序号 | 过出方 | 过入方 | 过户数量 | 占公司总股本 | 股份性质 | | --- | --- | --- | --- | --- | --- | | 1 | | | （股） | 比例 | | | | | 招立萍 | 2374595 | 0.7139% | 无限售流通股 | | 2 | | 赵新安 | 898508 | 0.2701% | | | 3 | | 顾玮彧 | 711657 | 0.2140% | | | 4 | 上海晶真文 | 凌青 | 561327 | 0.1688% | | | 5 | 化艺术发展 | 姜苏 | 336024 | 0.1010% | | | 6 | 中心（有限合 | 马亭 | 299 ...

Core Points - Aladdin's stock price decreased by 2.04% on November 17, trading at 13.42 CNY per share with a market capitalization of 4.464 billion CNY [1] - The company has seen an 18.42% increase in stock price year-to-date, with a 1.51% rise over the last five trading days and an 11.37% increase over the last 20 days, but a 13.36% decline over the last 60 days [2] - Aladdin's main business involves the research, production, and sales of reagents, with 96.96% of revenue coming from scientific reagents [2] - As of September 30, 2025, Aladdin reported a revenue of 444 million CNY, a year-on-year increase of 17.59%, while net profit attributable to shareholders decreased by 20.41% to 57.76 million CNY [2] Financials - The company has distributed a total of 241 million CNY in dividends since its A-share listing, with 150 million CNY distributed over the last three years [3] - As of September 30, 2025, the number of shareholders decreased by 7.17% to 11,600, while the average circulating shares per person increased by 7.72% to 28,729 shares [2] Shareholder Information - The top ten circulating shareholders have seen changes, with several funds exiting the list as of September 30, 2025 [3]

Core Viewpoint - The announcement details a change in the equity structure of Shanghai Aladdin Biochemical Technology Co., Ltd., primarily due to the dissolution and liquidation of its employee stock ownership platform, Shanghai Jingzhen Cultural and Artistic Development Center (Limited Partnership), which will lead to a non-trading transfer of shares among partners without affecting the company's control or governance structure [2][9][10]. Group 1: Equity Change Details - The equity change is initiated by the dissolution of the employee stock ownership platform, which will transfer shares to its partners through a non-trading transfer [2][9]. - After the completion of this non-trading transfer, the platform will no longer hold any shares in the company, and the overall shareholding of the controlling shareholder and actual controller will decrease [3][5]. - The platform currently holds 7,381,190 shares, accounting for 2.22% of the company's total equity [9]. Group 2: Shareholding Structure - The controlling shareholder, Zhao Liping, will see an increase in her shareholding after the transfer, while the platform's shareholding will be eliminated [3][10]. - The announcement specifies that the non-trading transfer will not lead to any change in the company's control or affect its governance structure and daily operations [2][9]. Group 3: Regulatory Compliance - The company will comply with the relevant regulations, including the disclosure of a simplified equity change report and the necessary procedures for the non-trading transfer [6][10]. - The transfer process will be handled by the China Securities Depository and Clearing Corporation Limited, Shanghai Branch [10][19].

Key Points - *ST Zhengping's stock will resume trading on November 12, 2025, after a significant increase of 152.42% from September 1 to October 28, 2025, with 21 days of trading halts and 5 instances of abnormal trading fluctuations [3] - Dongfang Zhizao plans to acquire 70% of Nantong Saifu Machinery Equipment Co., Ltd. for 27.4887 million yuan, making it a subsidiary [4] - Zhifei Biology received approval for clinical trials of a combined vaccine for adolescents and adults to prevent diphtheria, tetanus, and whooping cough [5] - CITIC Securities has been approved by the CSRC to issue up to 50 billion yuan in short-term corporate bonds [6] - Bangji Technology intends to terminate a major asset restructuring involving the acquisition of several companies, stating that current operations will not be adversely affected [7] - Dekeli is planning to issue S-shares and list on the Singapore Exchange as part of its global strategy [8] - Emei Mountain A announced that Leshan State Investment will transfer 90% of its stake in Emei Mountain Leshan Buddha Tourism Group to another state-owned entity without compensation, maintaining the current control structure [9] Performance Summary - Xincheng Development reported a contract sales amount of approximately 1.419 billion yuan in October 2025, with cumulative sales of about 16.468 billion yuan from January to October [11] - Huadong Holdings sold 242,500 pigs in October 2025, with a 19.85% month-on-month increase and a 20.80% year-on-year increase [13] - Xiamen Airport's passenger throughput in October was 2.5548 million, a year-on-year increase of 1.56% [14] Shareholding Changes - Huaguang Huaneng executives plan to reduce their holdings, with the chairman and several executives intending to sell up to 171,200 shares each [16] - Hot景 Biology announced a share buyback plan of 100 million to 200 million yuan for employee stock ownership or incentives [17] - Aladdin's controlling shareholder's stake decreased from 46.27% to 44.76% due to the dissolution of a partnership [18] - JianKai Technology's controlling shareholder plans to transfer 3% of the company's shares [19] - Yuyuan Holdings intends to repurchase shares worth 200 million to 300 million yuan at a price not exceeding 8.6 yuan per share [20] Major Contracts - China Oil Engineering's subsidiary won a project in Kazakhstan worth approximately 3.003 billion yuan for the construction of ethane and propane pipelines [22] - Dash Intelligent signed a contract for an intelligent display technology park project worth 12.7652 million yuan, which will positively impact its market share in the enterprise park sector [24]

Core Viewpoint - Aladdin (688179.SH) announced that its shareholder, Jingzhen Culture, intends to dissolve and liquidate, leading to a non-trading transfer of shares to its partners [1] Group 1: Shareholder Actions - Jingzhen Culture plans to apply for the non-trading transfer of its shares held in Aladdin to its partners through the China Securities Depository and Clearing Corporation Shanghai branch [1] - As of the announcement date, Jingzhen Culture holds 7,381,190 shares, representing 2.22% of the total share capital of Aladdin [1] Group 2: Company Structure - The executing partner of Jingzhen Culture is Zhao Liping, who is also the controlling shareholder of Aladdin [1] - Key personnel including directors, supervisors, and core technical staff are limited partners of Jingzhen Culture [1]

本次非交易过户完成后，晶真文化将不再持有公司股份，本次非交易过 户不会导致公司控制权发生变更，亦不会影响公司的治理结构和日常运营。 公司于近日收到信息披露义务人发来的《简式权益变动报告书》，现将本次 权益变动情况公告如下： 一、本次权益变动基本情况 | 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-072 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于控股股东、实际控制人权益变动的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： | 权益变动方向 | 比例增加□ | | 比例减少 | | --- | --- | --- | --- | | 权益变动前合计比例 | 46.27% | | | | 权益变动后合计比例 | 44.76% | | | | 本次变动是否违反已作出的承 | 是□ | 否 | | | 诺、意向、计划 | | | | | 是否触发强制要约收购义务 | 是□ | ...

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-071 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于公司股东拟解散清算并办理公司股份非交易过 户的提示性的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 因上海阿拉丁生化科技股份有限公司（以下简称"公司"）的员工持股 平台上海晶真文化艺术发展中心（有限合伙）（以下简称"晶真文化"）拟解散 清算，晶真文化拟通过证券非交易过户的方式登记至晶真文化各合伙人名下。 截至本公告披露日，晶真文化持有公司股份为 7,381,190 股，占公司总 股本 2.22%，股东晶真文化的执行事务合伙人为公司控股股东、实际控制人招立 萍女士，公司董事/监事/高管/核心技术人员赵新安、顾玮彧、王坤、沈鸿浩、 姜苏、马亭、赵悦、凌青、海龙为晶真文化的有限合伙人。 本次非交易过户完成后，晶真文化将不再持有公司股份，本次非交易过 户不会导致公司控制权发生变更，亦不会 ...

信息披露义务人二：招立萍 上海阿拉丁生化科技股份有限公司 简式权益变动报告书 上市公司名称:上海阿拉丁生化科技股份有限公司 股票代码：688179 信息披露义务人一：徐久振 住所及通讯地址：上海市*** 住所及通讯地址：上海市*** 信息披露义务人三：上海晶真文化艺术发展中心（有限合伙） 注册地址：中国（上海）自由贸易试验区临港新片区新四平公路 468 弄 14 幢 17 号 信息披露义务人四：上海仕创供应链有限公司 注册地址：上海市奉贤区南桥镇环城西路 477 号 1 层 权益变动性质：减少（非交易过户） 签署日期：2025 年 11 月 11 日 1 上市地点：上海证券交易所 股票简称：阿拉丁 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司收购管理办法》（以下简称"《收购办法》"）、《公开发行证券的公司信 息披露内容与格式准则第 15 号——权益变动报告书》（以下简称"《准则 15 号》"） 及相关的法律、法规和规范性文件编写本报告书。 | | | 第一节 释义 除非另有说明，以下简称在本报告书中作如下释义： 二、信息披露义务人签署本报告书已获得 ...

阿拉丁公告，控股股东、实际控制人招立萍女士控制的企业上海晶真文化艺术发展中心（有限合伙）拟 解散清算，通过证券非交易过户方式登记至各合伙人名下，导致控股股东、实际控制人及一致行动人合 计持有公司股份比例减少。权益变动前，控股股东、实际控制人及一致行动人合计持股比例为 46.27%；权益变动后，持股比例减少至44.76%。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、交易概述 ● 上海阿拉丁生化科技股份有限公司（以下简称"阿拉丁"或"公司"）全资子公司上海客学谷网络科技有 限公司（以下简称"客学谷"）拟以自有或自筹资金按比例购买喀斯玛（北京）科技有限公司（以下简 称"喀斯玛科技"）员工持股平台嘉兴科服投资合伙企业（有限合伙）（以下简称"嘉兴科服"）全体合伙 人分别持有的嘉兴科服40%的财产份额，按比例购买嘉兴科服间接合伙人嘉兴科旺企业管理咨询合伙企 业（有限合伙）（以下简称"嘉兴科旺"）的全体合伙人分别持有的嘉兴科旺40%财产份额；拟以自有或 自筹资金按比例购买喀斯玛科技员工持股平台嘉兴科进企业管理咨询合伙企业（有限合伙）（以下简 称"嘉兴科进"）的全体合伙人分别持有的嘉兴科进40%财产份额。具体内容详见公司于2025年10月30日 在上海证券交易所网站(www.sse.com.cn)披露的《上海阿拉丁生化科技股份有限公司关于全资子公司收 购控股孙公司持股平台财产份额的公告》（公告编 ...